Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

doi:10.1111/imm.13495

. 2022 Aug;166(4):539-542.

doi: 10.1111/imm.13495. Epub 2022 May 31.

Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Jorge Eguía^{1

2}, M Araceli Caballero-Rabasco^{2

3}, M Lourdes Cos^{2

4}, Santiago Grau⁵, Leonardo Mellibovsky^{2

4}, Eduardo Villegas^{1

2}, Fabiola Blasco^{4

6

7}, Ana Lemus^{4

6}, Marta Crespo⁸, Eduardo Padilla¹, Ramón Gimeno^{2

7

9

10}

Affiliations

¹ Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
² Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
³ Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
⁴ Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
⁵ Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
⁶ Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
⁷ Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
⁸ Department of Nephrology, Hospital del Mar, Barcelona, Spain.
⁹ Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.
¹⁰ Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

PMID: 35570365
PMCID: PMC9347869
DOI: 10.1111/imm.13495

Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Jorge Eguía et al. Immunology. 2022 Aug.

. 2022 Aug;166(4):539-542.

doi: 10.1111/imm.13495. Epub 2022 May 31.

Authors

Affiliations

¹ Laboratori de Referència de Catalunya SA, El Prat de Llobregat, Spain.
² Immunodeficiencies Unit, Hospital del Mar, Barcelona, Spain.
³ Department of Pediatrics, Hospital del Mar, Barcelona, Spain.
⁴ Department of Internal Medicine, Hospital del Mar, Barcelona, Spain.
⁵ Department of Pharmacy, Hospital del Mar, Barcelona, Spain.
⁶ Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain.
⁷ Laboratory of Immunology, Department of Pathology, Hospital del Mar, Barcelona.
⁸ Department of Nephrology, Hospital del Mar, Barcelona, Spain.
⁹ Immunity and Infection, Hospital del Mar Medical Research Institute, Barcelona, Spain.
¹⁰ Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona, Spain.

PMID: 35570365
PMCID: PMC9347869
DOI: 10.1111/imm.13495

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

1. Johns Hopkins University & Medicine . Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html Accessed November 2021
1. Shields AM, Burns SO, Savic S, Richter AG, UK PIN COVID‐19 Consortium . COVID‐19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5. - PMC - PubMed
1. Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648–56. - PMC - PubMed
1. Crespo M, Barrilado‐Jackson A, Padilla E, Eguía J, Echeverria‐Esnal D, Cao H, et al. Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant. 2021;22:786–800. 10.1111/ajt.16854 - DOI - PMC - PubMed
1. Wu J, Liang B, Chen C, Wang H, Fang Y, Shen S, et al. SARS‐CoV‐2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID‐19. Nat Commun. 2021;12(1):1813–22. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Johns Hopkins University & Medicine . Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html Accessed November 2021

[2] Johns Hopkins University & Medicine . Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/map.html Accessed November 2021

[3] Shields AM, Burns SO, Savic S, Richter AG, UK PIN COVID‐19 Consortium . COVID‐19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5. - PMC - PubMed

[4] Shields AM, Burns SO, Savic S, Richter AG, UK PIN COVID‐19 Consortium . COVID‐19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147(3):870–5. - PMC - PubMed

[5] Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648–56. - PMC - PubMed

[6] Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr. 2021;33(6):648–56. - PMC - PubMed

[7] Crespo M, Barrilado‐Jackson A, Padilla E, Eguía J, Echeverria‐Esnal D, Cao H, et al. Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant. 2021;22:786–800. 10.1111/ajt.16854 - DOI - PMC - PubMed

[8] Crespo M, Barrilado‐Jackson A, Padilla E, Eguía J, Echeverria‐Esnal D, Cao H, et al. Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant. 2021;22:786–800. 10.1111/ajt.16854 - DOI - PMC - PubMed

[9] Wu J, Liang B, Chen C, Wang H, Fang Y, Shen S, et al. SARS‐CoV‐2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID‐19. Nat Commun. 2021;12(1):1813–22. - PMC - PubMed

[10] Wu J, Liang B, Chen C, Wang H, Fang Y, Shen S, et al. SARS‐CoV‐2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID‐19. Nat Commun. 2021;12(1):1813–22. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Affiliations

Antibodies to SARS-CoV-2 in patients with primary immunodeficiencies treated with nonspecific immunoglobulins

Authors

Affiliations

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous